Found: 23
Select item for more details and to access through your institution.
A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 7, p. 1, doi. 10.1093/ofid/ofaa224
- By:
- Publication type:
- Article
Docetaxel and Carboplatin as Salvage Therapy for First-Relapsed, Platinum-Sensitive, Stage III/IV Advanced Ovarian Cancer.
- Published in:
- Clinical Ovarian & Other Gynecologic Cancer, 2015, v. 7, n. 1/2, p. 13, doi. 10.1016/j.cogc.2014.12.005
- By:
- Publication type:
- Article
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0631-3
- By:
- Publication type:
- Article
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 788, doi. 10.1111/bjh.13773
- By:
- Publication type:
- Article
Autologous haematopoietic cell transplantation for non- Hodgkin lymphoma with secondary CNS involvement.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 648, doi. 10.1111/bjh.12451
- By:
- Publication type:
- Article
The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34<sup>+</sup> cells.
- Published in:
- Journal of Clinical Apheresis, 2012, v. 27, n. 2, p. 81, doi. 10.1002/jca.21206
- By:
- Publication type:
- Article
Immunotherapy with Rituximab/Interleukin-2 After Autologous Stem Cell Transplantation as Treatment for CD20+ Non-Hodgkin's Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 2, p. 135
- By:
- Publication type:
- Article
KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characterization of Listeria monocytogenes-induced murine natural killer cells.
- Published in:
- Immunologic Research, 1986, v. 5, n. 1, p. 50, doi. 10.1007/BF02917194
- By:
- Publication type:
- Article
Fetal Tissue Banking for Transplantation: Characteristics of the Donor Population and Considerations for Donor and Tissue Screening.
- Published in:
- Cell & Tissue Banking, 2000, v. 1, n. 1, p. 45, doi. 10.1023/A:1010179805651
- By:
- Publication type:
- Article
Diagnosis and Management of Multiple Myeloma: A Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 775, doi. 10.1002/ajh.25818
- By:
- Publication type:
- Article
Prevention of Dimethylsulfoxide-Related Nausea and Vomiting by Prophylactic Administration of Ondansetron for Patients Receiving Autologous Cryopreserved Peripheral Blood Stem Cells.
- Published in:
- Oncology Nursing Forum, 2013, v. 40, n. 3, p. 285, doi. 10.1188/13.ONF.285-292
- By:
- Publication type:
- Article
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
- Published in:
- 2008
- By:
- Publication type:
- journal article
In-vivo purging of the circulating clonal T-cells with Alemtuzumab prior to autologous peripheral blood hematopoietic cell mobilization and transplantation.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 3, p. 415, doi. 10.1111/j.1365-2141.2011.08619.x
- By:
- Publication type:
- Article
A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphoma.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 151, n. 2, p. 193, doi. 10.1007/s11060-020-03648-9
- By:
- Publication type:
- Article
Dose Escalation of Busulfan with Pentoxifylline and Ciprofloxacin in Patients with Breast Cancer Undergoing Autologous Transplants.
- Published in:
- Oncology, 2004, v. 67, n. 5/6, p. 368, doi. 10.1159/000082920
- By:
- Publication type:
- Article
Bortezomib and Vorinostat Therapy as Maintenance Therapy Post-Autologous Transplant for Non-Hodgkin's Lymphoma Using R-BEAM or BEAM Transplant Conditioning Regimen.
- Published in:
- Acta Haematologica, 2024, v. 147, n. 3, p. 300, doi. 10.1159/000533944
- By:
- Publication type:
- Article
Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 2, p. 146, doi. 10.1159/000501298
- By:
- Publication type:
- Article
Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin.
- Published in:
- Acta Haematologica, 2017, v. 137, n. 3, p. 123, doi. 10.1159/000455937
- By:
- Publication type:
- Article
Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2179, doi. 10.1002/cncr.34778
- By:
- Publication type:
- Article